ONCOGENESIS in cholangiocarcinoma, a rare cancer, can be driven by the oncometabolite D-2-hydroxyglutarate, produced as a result of mutations in the isocitrate dehydrogenase 1 gene (IDH1). Dr Andrew X. Zhu delivered an oral presentation at the 2021 Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO GI 2021) entitled ‘Final Results from ClarIDHy, a Global, Phase III, Randomised, Double-Blind Study of Ivosidenib vs Placebo in Patients with Previously Treated Cholangiocarcinoma and an Isocitrate Dehydrogenase 1 (IDH1) Mutation’.
EMJ Oncology 9 [Supplement 2] . 2021
Latest articlesAll articles
A Review of the Latest Advancements in Ovarian Cancer Care Featured at ESMO 2022
Ovarian cancer is the seventh most commonly diagnosed cancer among females and the most lethal gynaecologic malignancy globally because of its vague presentation, insidious nature, recurrence, and drug resistance.
Marantic Endocarditis and Lung Adenocarcinoma with Brain Metastasis: A Diagnostic Conundrum
Non-bacterial endocarditis (also known as marantic endocarditis), a term coined by Gross and Fiedberg in 1936, encompasses the non-infectious (sterile) vegetations on structurally normal or superficially damaged cardiac valves in the absence of blood stream infection. Studies have postulated that local physical damage or cytokine mediated damage leads to platelet consumption, activation of clotting factors, and interlacing of fibrin strands that could be contributing to the vegetation formation.
The Role of Radical Radiotherapy in Sinonasal Myopericytoma: A Case Report and Literature Overview
Myopericytoma (previously defined haemangiopericytoma) is a rare vascular tumour originating from extracapillary cells called pericytes and rarely occurs in paranasal sinuses. Surgical wide resection is the treatment of choice. Post-operative radiotherapy is usually used in the case of incomplete resection.